Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2025-12-29 @ 6:27 PM
Study NCT ID:
NCT00748657
Status:
COMPLETED
Last Update Posted:
2019-07-23
First Post:
2008-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2013-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-05
First Submit QC Date:
None
Study First Post Date:
2008-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-27
Results First Submit QC Date:
None
Results First Post Date:
2015-06-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-19
Last Update Post Date:
2019-07-23
Last Update Post Date Type:
ACTUAL